Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
evidence of the efficacy of bevacizumab in patients with HHT.Both cases also show that symptoms and transfusion requirements improve with this therapy, without an appreciable change in arteriovenous malformations.Like Oosting et al., we found no difference in the size of our patient's pulmonary arteriovenous malformations on CT before and after bevacizumab.Their experience demonstrates the long-term safety and tolerability of bevacizumab in such patients.Our patient continues to report symptomatic benefit more than a year after completing therapy, and he has required only one intravenous infusion of iron during this time.His hemoglobin levels have remained stable at 14 to 15 g per deciliter.The cost of our patient's regimen (a total of 30 mg per kilogram over four cycles) would be approximately $12,000 today.The costs of continuing the drug in the long term, especially without a Food and Drug Administration-approved indication, would be prohibitive.Our case shows that intermittent dosing allows for long-term, symptomatic improvement and stability of pulmonary arteriovenous malformations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this patient, RDN resulted in a progressive decrease in blood pressure from 161/107 mmHg at baseline to 127/81 mmHg at 12-month follow-up.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“However, RDN-induced reductions in MSNA18 and beneficial effects of RDN on conditions that are not traditionally thought to be driven by the kidney, including heart failure and arrthymia19, cannot be wholly explained by alterations in body fluid homeostasis.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“ablation of the renal nerves was also associated with a substantial decrease in muscle sympathetic nerve activity (MSNA), from 56 bursts per minute before RDN to 19 bursts per minute at 12 months after the procedure.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“The hypothesis that renal afferents mediate some of the BP effects of RDN in humans was sparked by the finding that whole-body noradrenaline spillover and MSNA were decreased in a single patient 1 year after RDN170.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [170]
Citations
Cites
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citationNeural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Schlaich, M. P., Lambert, E., Kaye, D. M., Krozowski, Z., Campbell, D. J., Lambert, G., Hastings, J., Aggarwal, A., & Esler, M. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000103160.35395.9e · Cited by 514
Self-citationNoradrenaline Release and the Pathophysiology of Primary Human Hypertension
Esler, M., Jennings, G., & Lambert, G. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.3.140s · Cited by 138
Self-citation
Cited by
Items 501–600 of 763
Sesa‐Ashton, G., Woodhams, L., Herat, L. Y., & Schlaich, M. (2026) · Heart · doi:10.1136/heartjnl-2025-326186 · Cited by 4
“26 Patients were those with resistant hypertension.”
Self-citationBlood pressure management in clinically complex scenarios: new horizons for a tailored approach
Pastore, M. C., Liga, R., Diviggiano, E. E., Vitale, C. B., Parlato, A., Amati, F., D’Ascenzi, F., Imbalzano, E., Rinaldi, A., Scicchitano, P., et al. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004025 · Cited by 3
Sesa‐Ashton, G., Nolde, J. M., Tang, B., Carnagarin, R., Lambert, É., Lambert, G. W., Kiuchi, M. G., Macefield, V. G., Walton, A., Schultz, C. J., et al. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70112 · Cited by 4
“Renaldenervationdoesreducewhole-body norepinephrine spillover [19, 36] and single-unit muscle sympathetic nerve activity [14].”
InfluentialSelf-citationEthnicity and sympathetic tone: predictors of the blood pressure response to renal denervation?
Wang, Y. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.70-c1 · Cited by 3
Honarvar, M., Amirpour, A., & Pourmoghaddas, M. (2013) · PubMed Central · Cited by 3
Ablação da atividade simpática renal para tratamento da hipertensão arterial resistente
Gonçalves, P. D. A., Almeida, M., Branco, P. Q., Gaspar, A., Dores, H., Carvalho, M. S., Andrade, M. J., Weigert, A. L. L., Barata, J. D., Gomes, Â. C., et al. (2012) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2012.02.016 · Cited by 3
Leong, K. T. G., & Krum, H. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0414-y · Cited by 3
Self-citationLa dénervation rénale un traitement pour l’hypertension artérielle résistante : expérience française
Benamer, H., Mylotte, D., Garcia-Alonso, C., Unterseeh, T., Garot, P., Louvard, Y., Lefèvre, T., & Morice, M. (2013) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2013.09.003 · Cited by 3
Renal denervation for resistant hypertension: acute results and long-term follow-up.
Korovesis, S., Giazitzoglou, E., Pantos, I., Tzanalaridou, E., Kokladi, M., Venetsanakos, I., Paxinos, G., & Katritsis, D. G. (2014) · PubMed · Cited by 4
Denervação simpática renal: um novo cateter em um novo cenário
Staico, R., Armaganijan, L., Moreira, D. A. R., Medeiros, P. T. J., Habib, R. G., Neto, J. M., & Abizaid, A. (2013) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/s2179-83972013000400016 · Cited by 3
Performance Evaluation of Heat Exchangers in a Polyethylene Plant
Lebele-Alawa, B. T., & Ohia, I. O. (2013) · Open Journal Systems (Taiwan Association of Engineering and Technology Innovation) · Cited by 7
Więcek, A. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx227 · Cited by 3
“Catheter-based renal denervation (RDN) was introduced into clinical practice in 2009 [1] and immediately generated great hope and enthusiasm for the effective treatment of refractory hypertension as spectacular reductions of both systolic and diastolic blood pressure (BP) were achieved [2, 3].”
BackgroundMethods of sympathetic activity evaluation in patients with systemic refractory hypertension
Григин, В. А., Danilov, N. M., Sagaydak, O. V., Shelkova, G. V., & Чазова, И. Е. (2014) · Systemic Hypertension · doi:10.26442/2075-082x_11.4.21-26 · Cited by 5
Singh, R. R., McArdle, Z. M., Singh, H., Booth, L. C., May, C. N., Head, G. A., Moritz, K. M., Schlaich, M. P., & Denton, K. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94221-5 · Cited by 3
Self-citationGao, J., Xie, Y., Yang, W., Zheng, J., & Liu, Z. (2017) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2016.12.006 · Cited by 3
Catheter Ablation of Ventricular Fibrillation
Ezzeddine, F. M., Darlington, A. M., DeSimone, C. V., & Asirvatham, S. J. (2022) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2022.06.002 · Cited by 3
Radio Frequency-Based Renal Denervation: A Story of Simplicity?
Götzinger, F., Kunz, M., Lauder, L., Mahfoud, F., & Böhm, M. (2023) · Future Cardiology · doi:10.2217/fca-2023-0059 · Cited by 4
Non-pharmacological methods in the treatment of resistant hypertension
Kichukov, K. N., Dimitrov, H., Nikolova, L. K., Petrov, I. S., & Tokmakova, M. P. (2012) · Folia Medica · doi:10.2478/v10153-011-0081-y · Cited by 5
Renal denervation in a patient with two renal accessory arteries: A case report
Bertoldi, L. F., Latib, A., Piraino, D., Regazzoli, D., Sticchi, A., Pizzetti, G., Camici, P. G., & Colombo, A. (2013) · Blood Pressure · doi:10.3109/08037051.2013.778002 · Cited by 3
Emschermann, F., Zuern, C. S., Patzelt, J., Rizas, K. D., Jäger, G., Eick, C., Meuth, S. G., Gawaz, M., Bauer, A., & Langer, H. F. (2016) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2016.04.001 · Cited by 3
Renal denervation, adjusted drugs, or combined therapy for resistant hypertension: A meta-regression
Qi, X.-Y., Cheng, B., Li, Y., & Wang, Y. (2016) · Medicine · doi:10.1097/md.0000000000003939 · Cited by 5
“Although RD was designed to ablate the sympathetic nerves around renal artery, and to reduce the activity of sympathetic nerves in overactive patients through inhibiting renin angiotensin aldosterone system without renal function impairment.([30,31])”
BackgroundJeong, J., Brown, M. L. H., Kapuku, G. K., Harshfield, G. A., & Park, J. (2020) · Physiological Reports · doi:10.14814/phy2.14642 · Cited by 3
“Another important source of hemodynamic regulation, during and after stress, is sodium handling via increased renal sympathetic activation (Johns et al., 2011; Schlaich et al., 2009).”
BackgroundTemperature detection system for Renal Denervation Catheter application
Gourikutty, S. B. N., Choong, D. S. W., Lim, R., Damalerio, R., Oh, J., Kim, Y., Bae, I., & Cheng, M. (2020) · IEEE Electronics Packaging Technology Conference (EPTC) · doi:10.1109/eptc50525.2020.9315073 · Cited by 4
“Neutralizing such nerves has been recommended as an efficient way to control hypertension [7, 8, 9].”
BackgroundRipp, T. M., Mordovin, V. F., Pekarskiy, S. E., Ryabova, T. R., Злобина, М. В., Krilov, A., Lechikaki, V. A., Popov, S. V., & Karpov, R. S. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-2-139-147 · Cited by 3
The Role of Nonpharmacologic Device Interventions in the Management of Drug-Resistant Hypertension
Frishman, W. H., & Glicklich, D. G. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0405-5 · Cited by 5
Drug-resistant Hypertension: Is Renal Sympathetic Denervation the Answer?
Thompson, K. A., Kar, S., Makkar, R. R., & Victor, R. G. (2011) · Current Cardiology Reports · doi:10.1007/s11886-010-0166-x · Cited by 3
“Following encouraging results of an uncontrolled feasibility trial and a case report [7, 8], a recent randomized controlled trial (Symplicity HTN-2 [Renal Denervation in Patients With Uncontrolled Hypertension]) has further demonstrated the potential for catheter-based renal denervation in the treatment of drug-resist…”
Transcatheter therapies for resistant hypertension: Clinical review
Lokhandwala, A. M., & Dhoble, A. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.706 · Cited by 4
Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease
Hoye, N. A., Baldi, J. C., Putt, T. L., Schollum, J. B., Wilkins, G. T., & Walker, R. J. (2013) · Clinical Kidney Journal · doi:10.1093/ckj/sft130 · Cited by 3
“Keen interest has been generated in the technique’s sympatholytic effects [7, 8], particularly in CKD research circles.”
BackgroundRenal sympathetic denervation for treatment of resistant hypertension
Gonçalves, P. D. A., Almeida, M., Branco, P. Q., Gaspar, A., Dores, H., Carvalho, M. S., Andrade, M. J., Weigert, A. L. L., Barata, J. D., Gomes, Â. C., et al. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.07.010 · Cited by 3
Technical aspects of renal denervation in end-stage renal disease patients with challenging anatomy
Spinelli, A., Ros, V. D., Morosetti, D., D'Onofrio, S., Rovella, V., Daniele, N. D., & Simonetti, G. (2014) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2013.13408 · Cited by 3
Yerasi, C., Baker, N. C., Jonnalagadda, A. K., Torguson, R., Singh, S., Vies, J., & Waksman, R. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.10.002 · Cited by 6
Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for “Prime Time”?
Laffin, L. J., & Bakris, G. L. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw123 · Cited by 4
The Role of Renal Sympathetic Denervation in Atrial Fibrillation.
Kosiuk, J., Pokushalov, E., Hilbert, S., Hindricks, G., Bollmann, A., & Md, J. S. S. (2014) · Europe PMC (PubMed Central) · doi:10.4022/jafib.987 · Cited by 3
Renale Denervierung: Atueller Stand und Perspektiven
Kara, K., Bruck, H., Kahlert, P., Plicht, B., Mahabadi, A. A., Konorza, T. F. M., & Erbel, R. (2012) · Herz · doi:10.1007/s00059-012-3689-7 · Cited by 4
Wang, Y., Denton, K. M., & Golledge, J. (2013) · Hypertension Research · doi:10.1038/hr.2013.82 · Cited by 3
Rationale of Novel Interventions for Resistant Hypertension
Toorop, R. J., Scheltinga, M. R., Ricco, J., & Moll, F. L. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2011.07.014 · Cited by 3
Lembo, G., & Grassi, G. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283462d0d · Cited by 3
Nonpharmacological treatments for hypertension
Sleight, P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328356d99c · Cited by 3
“Of course this new article by Alnima et al. [6] in the current journal, which is focused on the arterial baroreflex, does not mention the elephant in the room – namely the exciting recent data from Esler’s group in Australia [1,2,7,9] – concerning equally large falls in BP to those seen with baroreflex stimulation.”
Background123I-mIBG scintigraphy: Clinical tool for assessing renal sympathetic activity?
George, C., Bhambhvani, P. G., & Oparil, S. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0764-0 · Cited by 3
“In contrast, renal NE spillover is selective for the kidney, and elevations in renal NE spillover in hypertensive patients,(27) as well as reductions in renal NE spillover after renal artery denervation, have been demonstrated.(7,28) Future studies designed to determine whether there is a relationship between renal (1…”
BackgroundLee, Y. S. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2019.0361 · Cited by 3
Acetate concentration correlates with MSNA in patients with resistant hypertension
Carnagarin, R., Sesa‐Ashton, G., Ward, N. C., Nolde, J. M., Joyson, A., Chan, J., Jose, A., & Schlaich, M. P. (2025) · Clinical Autonomic Research · doi:10.1007/s10286-025-01144-6 · Cited by 2
“It is well established that sympathetic drive, whether measured by MSNA or noradrenaline spillover, is markedly elevated in patients with resistant hypertension [4, 15, 16].”
Self-citationRenal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome
Tokcan, M., Hohl, M., Schneider, C. V., Schneider, K. M., Markwirth, P., Bernhard, B., Haring, B., Lauder, L., Schattenberg, J. M., Mahfoud, F., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26601 · Cited by 2
Denker, M. G., Cohen, D. L., & Townsend, R. R. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0535-4 · Cited by 3
Renal Denervation Therapies for Refractory Hypertension
Granada, J. F., & Buszman, P. P. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0303-9 · Cited by 2
Renal Sympathetic Denervation: From Bench to Bedside or the Other Way Around?
Peruzzi, G. (2013) · Translational Medicine · doi:10.4172/2161-1025.1000e113 · Cited by 2
“These procedure appears to have several potential advantages, including of course the reduction in both SBP and DBP, and the requirement for fewer antihypertensive medications [6,8].”
BackgroundRenal sympathetic denervation: indications, contemporary devices and future directions
Sathananthan, J., Watson, T., Whitbourn, R., Stewart, J. T., Doughty, R. N., Ormiston, J. A., & Webster, M. W. I. (2014) · Interventional Cardiology · doi:10.2217/ica.13.82 · Cited by 2
Endovascular radiofrequency renal denervation in resistant hypertension: a single center experience
Negro, A., Manari, A., Santi, R., Grasselli, C., Davoli, S., Pignatelli, G., Menozzi, M., & Perazzoli, F. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2013.174 · Cited by 2
Lee, D. P. (2020) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2020.07.004 · Cited by 2
Tung, M. L., Kobayashi, T., Swaminathan, R. V., Cohen, D. L., Feldman, D. N., & Fulton, B. L. (2025) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2024.11.008 · Cited by 4
Heart rate variability in a patient after percutaneous renal denervation: a case report
Baksh, T., & Bidikar, M. P. (2013) · International Journal of Research in Medical Sciences · doi:10.5455/2320-6012.ijrms20131151 · Cited by 2
Okamura, K., Satou, S., Setojima, K., Shono, S., Miyajima, S., Ishii, T., Shirai, K., & Urata, H. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.908891 · Cited by 2
“Direct evaluation of the sympathetic nerve system in humans can be performed by recording muscle sympathetic nerve activity and isotopic assessment of norepinephrine spillover [10], but these are invasive methods.”
MethodRenal Denervation: Paradise Lost? Paradise Regained?
Padmanabhan, D., Isath, A. M., & Gersh, B. J. (2018) · US Cardiology Review · doi:10.15420/usc.2018.1.2 · Cited by 2
“Schlaich further demonstrated a sustained decrease in BP from 161/107 to 127/81 mmHg at 12 months following bilateral renal artery ablation (Figure 1).(10)”
BackgroundEndocannabinoid system: An untold story in hypertensive nephropathy
Ahmad, A. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/13055 · Cited by 1
Armaganijan, L., Staico, R., Moreira, D. A. R., Amodeo, C., Borelli, F. A. D. O., de Sousa, M. G., Sousa, A., & Abizaid, A. (2014) · Revista Brasileira de Cardiologia Invasiva · doi:10.1590/0104-1843000000027 · Cited by 2
Targeting Blood Pressure Lowering and the Sympathetic Nervous System
Hering, D., & Narkiewicz, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801387-8.00027-2 · Cited by 2
Lurz, P. C., Okon, T., Riede, T., Wagner, R., Schuler, G. C., Dähnert, I., & Desch, S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.09.034 · Cited by 2
Angle, J. F., Prince, E. A., Matsumoto, A. H., Lohmeier, T. E., Roberts, A. M., Misra, S., Razavi, M. K., Katholi, R. E., Sarin, S. N., Sica, D. A., et al. (2014) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2013.12.572 · Cited by 2
“The first reported patient to undergo RDN demonstrated a substantial reduction in whole-body NE spillover and MSNA measurements at 1 and 12 months (8).”
BackgroundCatheter based radiofrequency ablation of renal nerves for the treatment of resistant hypertension
Schlaich, M. P., Hering, D., & Esler, M. (2011) · Italian Journal of Medicine · doi:10.1016/j.itjm.2011.09.001 · Cited by 2
“1 g/m(2)) at 12 months follow-up compared to baseline [7].”
BackgroundSelf-citationImbalzano, E., Mandraffino, G., Ceravolo, R., Stefano, R. D., & Saitta, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.100 · Cited by 2
“In six patients (3 men and 3 women, mean age 63 ± 7.5 years) with a medical history of R-HTN, we measured clinic (sphygmomanometer), and ambulatory (Tonoport V GE Healthcare, Horten, Norway) blood pressure together with heart rate (electrocardiogram), at baseline and 30 days after RSD procedure (Symplicity; Medtronic,…”
BackgroundInfluentialOparil, S. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0211-4 · Cited by 2
“A detailed study of the effects of renal nerve ablation in a patient with long-standing treatment-resistant hypertension provided new insights into the mechanisms by which the intervention lowers BP and protects target organs [8].”
BackgroundResultOne swallow does not a summer make: Safety and renal denervation
Patel, H. C., & Salukhe, T. V. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.163 · Cited by 2
“Through its effects on the afferent nerves, RDN also reduces global SNS activation as shown by using the noradrenaline spillover technique and MSNA assessment [19].”
MethodAre We on the Path to Solve the Enigma of Resistant Hypertension: Renal Sympathetic Denervation
Gerc, V., & Buksa, M. (2013) · Medical Archives · doi:10.5455/medarh.2013.67.454-459 · Cited by 3
“Measurements of noradrenaline spillover may help with estimating the activity of the efferent renal sympathetic nerve (19, 20, 21).”
BackgroundContemporary Reviews in Cardiovascular Medicine Cardiorenal Syndrome New Perspectives
Bock, J. S., Stephen, M., & Gottlieb, S. S. (2016) · Cited by 2
Harnessing the Autonomic Nervous System for Therapeutic Intervention
Esler, M. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00137-2 · Cited by 2
Self-citationCatheter-Based Renal Sympathetic Denervation for Resistant Hypertension: A Meta- Analysis
Macedo, F. (2013) · International Journal of Cardiovascular Research · doi:10.4172/2324-8602.1000116 · Cited by 2
“The procedure has been shown to be safe and feasible in Europe [13,14].”
BackgroundInterventional approaches for resistant hypertension
Davidson, A. C., & Bisognano, J. D. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328356d004 · Cited by 3
Resistant systemic hypertension
al baba, B. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328343e9e0 · Cited by 2
Renal Denervation: Current Status and Future Applications
Gomez, S., Urbandt, P., Beohar, N., & Santana, O. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0720 · Cited by 2
Chen, X.-H., Kim, S., Zeng, X.-X., Chen, Z.-B., Cui, T.-L., Hu, Z., Li, Y., & Fu, P. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.208238 · Cited by 2
“[22] An early clinical evaluation has demonstrated that catheter‐based RDN could lower BP in patients with RH by decreasing renal norepinephrine spillover, halving of renin activity, increasing renal plasma flow, and reducing central sympathetic drive.[23] However, RCTs designed to confirm the early clinical evaluatio…”
BackgroundResultFrohlich, E. D. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.02.019 · Cited by 2
Ambulatory arterial stiffness index and blood pressure response to renal denervation
Burnier, M. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001714 · Cited by 2
Unaltered neurocardiovascular reactions to mental stress after renal sympathetic denervation
Völz, S., Lundblad, L. C., Andersson, B., Multing, J., Rundqvist, B., & Elam, M. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2019.1590387 · Cited by 2
Chinushi, M., Saitoh, O., Sugai, A., Oikawa, A., Watanabe, J., & Furushima, H. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.07.029 · Cited by 2
Stress and Salt Sensitivity in Childhood Hypertension
Hanevold, C. D., & Harshfield, G. A. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-490-6_18 · Cited by 2
“Esler and his colleagues have conducted studies demonstrating successful and enduring treatment of refractory hypertension with renal sympathetic nerve ablation [ 61 , 62 ].”
BackgroundRenal denervation: a new therapeutic approach for resistant hypertension
Longxing, C., Fu, Q., Binghui, W., & Li, Z. (2014) · Chinese Medical Journal · doi:10.1097/00029330-201409200-00020 · Cited by 3
Sousa, H., Branco, P. Q., Almeida, M., Gonçalves, P. D. A., Gaspar, A., Dores, H., Mesquita, J., Andrade, M. J., Neuparth, N. M. B., Aleixo, A., et al. (2017) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2016.09.014 · Cited by 2
The impact of renal denervation procedure on use of antihypertensive drugs in the real-life setting
Rea, F., Morabito, G., Savaré, L., Corrao, G., & Mancia, G. (2022) · Blood Pressure · doi:10.1080/08037051.2022.2126345 · Cited by 2
“One of these influences is the activity of the sympathetic nervous system which is high in resistant hypertension [25] and reduced by renal denervation [26,27].”
BackgroundBelly fat and resistant hypertension
Jordan, J., & Grassi, G. M. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328339b8d9 · Cited by 3
Erythrocyte Salt Sedimentation Assay Does Not Predict Response to Renal Denervation
Vonend, O., Martin, O., Rump, L. C., Kröpil, P., & Stegbauer, J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00051 · Cited by 2
“by norepinephrine spillover or muscle sympathetic nerve activity) would certainly be the gold standard to select patients with sympathetic overactivity for RDN (8).”
BackgroundRakhmadi, A., & Saitô, K. (2023) · IEICE Transactions on Electronics · doi:10.1587/transele.2023ecp5002 · Cited by 2
Fiber based infrared lasers and their applications in medicine, spectroscopy and metrology
Alexander, V. V. (2013) · Deep Blue (University of Michigan) · Cited by 2
Renal Nerve Ablation for Resistant Hypertension
Gradman, A. H. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0189-8 · Cited by 2
“Recent reports have documented the dramatic effects that these treatments may have in selected patients with drugresistant hypertension [ 2 , 3]. The Symplicity HTN-2 Trial recently published in The Lancet and reviewed here is the first randomized trial of percutaneous RNA for drugresistant hypertension.”
BackgroundThe link between renal denervation and reduction of cardiovascular risks: Simplicity or not?
Amasyalı, B., Kılıç, A., & Oylumlu, M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.101 · Cited by 2
“When we look through the window of hypertension, the renal nerves have been identified as important contributors in both development and maintenance of hypertension [2].”
BackgroundRenal denervation in hypertension: is it the end or the beginning of a SPYRAL?
Burnier, M., Narkiewicz, K., Kjeldsen, S. E., & Oparil, S. (2017) · Blood Pressure · doi:10.1080/08037051.2017.1386539 · Cited by 2
“tion, have generated a fantastic upward spiral of enthusiasm for this new approach of treating resistant hypertension [1,2].”
BackgroundSee, A. Y. S., Blazeska, E., Shaban, A. A., Thomas, M. R., Nejad, S. H., Dornelles, A. S., Joyson, A., Burrows, S., Schlaich, M. P., & Thiruvengadam, S. (2024) · Kidney & Blood Pressure Research · doi:10.1159/000541568 · Cited by 1
Self-citationRecent advances in the approach to catheter-based renal denervation
Sesa‐Ashton, G., Carnagarin, R., Woodhams, L., Herat, L. Y., & Schlaich, M. P. (2026) · Expert Review of Medical Devices · doi:10.1080/17434440.2026.2684988 · Cited by 1
“First in human experiments were completed in 2009 in Melbourne, Australia, and revealed that a catheter-based approach utilizing radiofrequency ablation of the bilateral renal arteries lead to a pronounced blood pressure fall in patients with resistant hypertension [37,38].”
Self-citationChen, L., Lin, H., Chen, X., Sun, M., Li, Z., Su, X., Peng, H., Wang, Y., & Cheng, Y. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108981 · Cited by 1
Autonomic Dysfunction in Hypertension
Parati, G., & Ochoa, J. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-43036-7_3 · Cited by 2
Renal Denervation: From Historical Roots to the Modern Therapeutic Paradigm
Morrison, L., & Vishnevsky, A. (2026) · Journal of CardioRenal Medicine · doi:10.3390/jcrm2020007 · Cited by 1
“This led to the development of catheter-based renal denervation (RDN), utilizing radiofrequency energy, ultrasound, or neurotoxic agents to ablate perivascular renal nerves via a minimally invasive endovascular approach [15].”
Brachmann, J., Schnupp, S., & Blüm, B. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.06.009 · Cited by 2
Interventionelle Therapiestrategien bei resistenter Hypertonie
Linnenweber-Held, S., Schmidt, B. M. W., & Menne, J. (2011) · Der Nephrologe · doi:10.1007/s11560-011-0543-5 · Cited by 1
La dénervation rénale un traitement pour l’hypertension artérielle résistante
Benamer, H., Louvard, Y., Garot, P., Unterseeh, T., Hovasse, T., Lefèvre, T., Chevalier, B., & Morice, M. (2011) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2011.09.005 · Cited by 1
Dénervation rénale par voie radiale pour le traitement d’une hypertension artérielle résistante
Garcia-Alonso, C., Unterseeh, T., Garot, P., Louvard, Y., Lefèvre, T., Morice, M. C., & Benamer, H. (2014) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2014.09.030 · Cited by 1
Renale Denervation: Schweizer Erfahrungen im Langzeitverlauf
Sudano, I., Battegay, E. J., Erné, P., & Lüscher, T. F. (2015) · Praxis · doi:10.1024/1661-8157/a001885 · Cited by 1
“Experimentell konnte bereits seit langem gezeigt werden, dass eine Unterbrechung der afferenten Nerven aus den Nieren über eine verminderte Aktivierung der kardiovaskulären Zentren des Hirn stamms zu beeindruckenden Blutdruck senkungen führen kann [10-13].”
BackgroundRenal denervation in the treatment of resistant arterial hypertension and other perspectives
Poloczek, M., Vysočanová, P., Miklík, R., Nykl, I., & Kala, P. (2012) · Cor et Vasa · doi:10.1016/j.crvasa.2012.05.012 · Cited by 1
Baumbach, A., Burchell, A. E., Hart, E. C., Nightingale, A. K., & Paton, J. F. R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.028 · Cited by 1
“This is in contrast to earlier reports of RDN cohorts, which documented high MSNA with a fall following the procedure [1,2].”
BackgroundResultDenervación simpática renal en la hipertensión arterial resistente
Rivas, N. M., Vallejo, E. C., Méndez‐Bailón, M., & Cuevas, G. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.04.005 · Cited by 1
Karimkhani, B. A. C. (2014) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000284 · Cited by 1
“An additional study demonstrated reduction in renin release as well as increased renal blood flow with RDN [33].”
BackgroundRenal sympathetic denervation as antihypertensive therapy--a reappraisal of first results
Veelken, R. A., & Mann, J. F. E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft017 · Cited by 1
Renal Denervation: Unde Venis et Quo Vadis?
Nähle, C. P., Düsing, R., & Schild, H. H. (2015) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0034-1385526 · Cited by 1
“…and human studies [15, 19], the HTN-3 study as the first controlled, randomized, and blinded study after the initial positive study results [33, 40, 51] provided sobering information with respect to blood pressure reduction by renal denervation being superior to optimal treatment with medication…”
Metadata
- Authors
- Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- University of Oklahoma Health Sciences Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-08-27
- Volume
- 361
- Issue
- 9
- Pages
- 932-934
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1994487234
- Cited by
- 772
- References
- 5
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 19 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 19 · 2019: 27 · 2018: 31 · 2017: 42 · 2016: 42 · 2015: 52 · 2014: 115 · 2013: 136 · 2012: 95
- FWCI
- 42.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- uncontrolled hypertension, bevacizumab, hereditary hemorrhagic telangiectasia, pulmonary arteriovenous malformation, intermittent dosing, long-term drug safety, iron requirements
- MeSH terms
- Humans, Hypertension, Kidney, Male, Middle Aged, Norepinephrine, Renal Artery, Sympathectomy, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.